自然衍生生物活性化合物作为精确调节器的免疫和炎症机制在牛皮的条件下
Ada Radu1,2, Delia Mirela Tit1,2, Laura Maria Endres1,3
1Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087, Oradea, Romania.
Inflammopharmacology
|November 22, 2024
概括
像黄酸和omega-3脂肪酸这样的天然化合物在治疗牛皮炎症和氧化应激方面表现有前途. 需要进行进一步的研究,以优化它们的使用,并确保牛皮治疗的安全性.
科学领域:
- 皮肤病学和免疫学
- 自然产品化学 自然产品化学
背景情况:
- 牛皮是一种慢性自身免疫性皮肤疾病,治疗治疗方法有限.
- 目前的疗法有不良影响,包括免疫抑制和癌症风险.
- 天然生物活性化合物为更安全的牛皮管理提供了潜力.
研究的目的:
- 审查天然生物活性化合物对牛皮的治疗潜力.
- 探索黄类,特类,欧米茄-3脂肪酸和类的免疫调节和抗炎性质.
- 为了解决当前牛皮治疗方法的局限性.
主要方法:
- 现有研究的叙述性审查.
- 专注于评估免疫调节和抗炎作用的实验模型.
- 对生物活性化合物的分析,包括黄类,特类,欧米茄-3脂肪酸和类.
主要成果:
- 天然生物活性化合物在减少牛皮症状方面表现出有效性.
- 这些化合物可以用作独立或补充治疗.
- 有证据表明,它有可能减少炎症和氧化应激.
结论:
- 天然化合物为牛皮治疗提供了一个有希望的途径,副作用较少.
- 需要进一步进行临床试验,以确定最佳使用和安全性.
- 包括这些化合物的个性化治疗策略需要进行调查.
相关概念视频
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Inflammatory Bowel Disease IV: Pharmacological Management
113
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
113
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142


